Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bipolar Disorder is a type of affective disorder in which the patient has both manic or mild manic episodes and depressive episodes.Bipolar Disorder Therapeutic refers to treatments for this psychological disorder.
The global Bipolar Disorder Therapeutic market will reach $5.2 billion by 2026. North America accounted for the largest market share due to the rising prevalence of bipolar disorder in North America. This can be attributed to high stress levels, sleep deprivation and the trend of substance abuse among the population. Moreover, government initiatives aimed at raising awareness and supporting people with bipolar disorder are also expected to drive the market growth in the region. For instance, the Center for Mental Health Services (CMHS) of the Substance Abuse and Mental Health Services Administration (SAMHSA) under the U.S. Department of Health and Human Services expanded its support for mental health treatment and recovery in 2016. The Asia-Pacific region is expected to grow at a higher rate, which can be attributed to the high prevalence of mental illness in the region. According to data released by the World Health Organization, India and China are among the countries most affected by mental disorders such as anxiety disorders, schizophrenia, and bipolar disorder. Some governments are allocating funds for bipolar research and conducting awareness campaigns to remove the stigma associated with bipolar disorder and increase treatment and compliance rates among the general population. Scientific and medical institutions are also playing an active role by conducting research and developing new drugs and therapies for bipolar disorder.
Rising prevalence of bipolar disorder due to competitive social pressures, surge in work-life stress among the urban living population, government support for causing awareness about bipolar disorder, and technological advancements that help in accurate detection of emotional and mental state of patients are some of the key factors driving the growth of the Bipolar Disorder Therapeutic market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Bipolar Disorder Therapeutic market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Bipolar Disorder Therapeutic market. Detailed analysis of key players, along with key growth strategies adopted by Bipolar Disorder Therapeutic industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Eli Lilly
Allergan
Janssen Pharmaceuticals
AstraZeneca
Astellas Pharma
GlaxoSmithKline
Bristol-Myers Squibb
By Type:
Antipsychotics
Anticonvulsants
Mood Stabilizers
By End-User:
medical treatment
psychological counselling
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Bipolar Disorder Therapeutic Market
-
1.3 Market Segment by Type
-
1.3.1 USA Bipolar Disorder Therapeutic Market Size and Growth Rate of Antipsychotics from 2016 to 2027
-
1.3.2 USA Bipolar Disorder Therapeutic Market Size and Growth Rate of Anticonvulsants from 2016 to 2027
-
1.3.3 USA Bipolar Disorder Therapeutic Market Size and Growth Rate of Mood Stabilizers from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Bipolar Disorder Therapeutic Market Size and Growth Rate of medical treatment from 2016 to 2027
-
1.4.2 USA Bipolar Disorder Therapeutic Market Size and Growth Rate of psychological counselling from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Bipolar Disorder Therapeutic Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Bipolar Disorder Therapeutic by Major Types
-
3.4.1 Market Size and Growth Rate of Antipsychotics
-
3.4.2 Market Size and Growth Rate of Anticonvulsants
-
3.4.3 Market Size and Growth Rate of Mood Stabilizers
4 Segmentation of Bipolar Disorder Therapeutic Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Bipolar Disorder Therapeutic by Major End-Users
-
4.4.1 Market Size and Growth Rate of Bipolar Disorder Therapeutic in medical treatment
-
4.4.2 Market Size and Growth Rate of Bipolar Disorder Therapeutic in psychological counselling
5 Market Analysis by Regions
-
5.1 USA Bipolar Disorder Therapeutic Production Analysis by Regions
-
5.2 USA Bipolar Disorder Therapeutic Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Bipolar Disorder Therapeutic Landscape Analysis
-
6.1 West USA Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
6.2 West USA Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
7 South USA Bipolar Disorder Therapeutic Landscape Analysis
-
7.1 South USA Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
7.2 South USA Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
8 Middle West USA Bipolar Disorder Therapeutic Landscape Analysis
-
8.1 Middle West USA Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
8.2 Middle West USA Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
9 Northeast USA Bipolar Disorder Therapeutic Landscape Analysis
-
9.1 Northeast USA Bipolar Disorder Therapeutic Landscape Analysis by Major Types
-
9.2 Northeast USA Bipolar Disorder Therapeutic Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Eli Lilly
-
10.1.1 Eli Lilly Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Allergan
-
10.2.1 Allergan Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Janssen Pharmaceuticals
-
10.3.1 Janssen Pharmaceuticals Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 AstraZeneca
-
10.4.1 AstraZeneca Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Astellas Pharma
-
10.5.1 Astellas Pharma Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 GlaxoSmithKline
-
10.6.1 GlaxoSmithKline Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Bristol-Myers Squibb
-
10.7.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Bipolar Disorder Therapeutic Market Size and Growth Rate of Antipsychotics from 2016 to 2027
-
Figure USA Bipolar Disorder Therapeutic Market Size and Growth Rate of Anticonvulsants from 2016 to 2027
-
Figure USA Bipolar Disorder Therapeutic Market Size and Growth Rate of Mood Stabilizers from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Bipolar Disorder Therapeutic Market Size and Growth Rate of medical treatment from 2016 to 2027
-
Figure USA Bipolar Disorder Therapeutic Market Size and Growth Rate of psychological counselling from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Bipolar Disorder Therapeutic Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Bipolar Disorder Therapeutic Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Bipolar Disorder Therapeutic
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Bipolar Disorder Therapeutic by Different Types from 2016 to 2027
-
Table Consumption Share of Bipolar Disorder Therapeutic by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Antipsychotics
-
Figure Market Size and Growth Rate of Anticonvulsants
-
Figure Market Size and Growth Rate of Mood Stabilizers
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Bipolar Disorder Therapeutic by Different End-Users from 2016 to 2027
-
Table Consumption Share of Bipolar Disorder Therapeutic by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of medical treatment
-
Figure Market Size and Growth Rate of psychological counselling
-
Table USA Bipolar Disorder Therapeutic Production by Regions
-
Table USA Bipolar Disorder Therapeutic Production Share by Regions
-
Figure USA Bipolar Disorder Therapeutic Production Share by Regions in 2016
-
Figure USA Bipolar Disorder Therapeutic Production Share by Regions in 2021
-
Figure USA Bipolar Disorder Therapeutic Production Share by Regions in 2027
-
Table USA Bipolar Disorder Therapeutic Consumption by Regions
-
Table USA Bipolar Disorder Therapeutic Consumption Share by Regions
-
Figure USA Bipolar Disorder Therapeutic Consumption Share by Regions in 2016
-
Figure USA Bipolar Disorder Therapeutic Consumption Share by Regions in 2021
-
Figure USA Bipolar Disorder Therapeutic Consumption Share by Regions in 2027
-
Table West USA Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table West USA Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure West USA Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure West USA Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure West USA Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table West USA Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table West USA Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure West USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure West USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table South USA Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table South USA Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure South USA Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure South USA Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure South USA Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table South USA Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table South USA Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure South USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure South USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table Middle West USA Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table Middle West USA Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure Middle West USA Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure Middle West USA Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table Middle West USA Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure Middle West USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure Middle West USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table Northeast USA Bipolar Disorder Therapeutic Consumption by Types from 2016 to 2027
-
Table Northeast USA Bipolar Disorder Therapeutic Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Bipolar Disorder Therapeutic Consumption Share by Types in 2016
-
Figure Northeast USA Bipolar Disorder Therapeutic Consumption Share by Types in 2021
-
Figure Northeast USA Bipolar Disorder Therapeutic Consumption Share by Types in 2027
-
Table Northeast USA Bipolar Disorder Therapeutic Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Bipolar Disorder Therapeutic Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2016
-
Figure Northeast USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2021
-
Figure Northeast USA Bipolar Disorder Therapeutic Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Janssen Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Janssen Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Janssen Pharmaceuticals
-
Table Product and Service Introduction of Janssen Pharmaceuticals
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Astellas Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma
-
Figure Sales and Growth Rate Analysis of Astellas Pharma
-
Figure Revenue and Market Share Analysis of Astellas Pharma
-
Table Product and Service Introduction of Astellas Pharma
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
